Figure 1
@Figure1
Followers
13K
Following
5K
Media
2K
Statuses
5K
Sharpen your clinical knowledge. Join 3 million HCPs using Figure 1 to share and discuss medical cases. Download the app or visit https://t.co/nKKBtk15lZ
Joined March 2013
With over 100,000 real patient cases and 3 million members, Figure 1 is changing the future of #MedicalEducation. Join the largest global community of medical minds and start collaborating: https://t.co/T6uPB618UC
1
2
9
ELCC 2026 is coming — Copenhagen, March 25–28 🫁 Follow our dedicated ELCC 2026 profile on the Figure 1 app for expert insights as they happen: https://t.co/t5cz5gShUq
#ELCC26 #esmomeetings #LungCancer #ThoracicOncology #LungCancerResearch
0
0
1
Save the date: Oncology Forum returns May 31 in Chicago After ASCO’s plenary and key data, join focused, expert‑led discussions to unpack what matters and what to do next. Step off the floor and talk it through with peers. Learn more: https://t.co/utxprmjL89
#OncForum2026
0
0
2
Big news! DDx has been named one of @FeedSpot's Top 100 Doctor Podcasts AND a Top 45 Canadian Doctor Podcast 🏆 Thank you to our incredible community of listeners! Catch up on all 12 seasons here: https://t.co/pA09khAq4z
#MedTwitter #MedicalPodcast #MedEd #ClinicalLearning
0
0
2
Introducing the Community Tab in Figure 1 🩺 ✅ Accounts to Follow ✅ Your Groups ✅ Interactive Case Labs Debates ✅ Public Groups ✅ Expert Feeds from real doctors Update the app & check it out. #MedTwitter #MedEd #ClinicalLearning #PatientCare
0
0
1
Can one diabetic patient change how you treat GCA? @ebrheum shares the case that shifted his thinking on steroids → short tapers + steroid-sparing therapy. Watch: https://t.co/gRQjLYx7Hc
#GiantCellArteritis #MedEd #MedTwitter #Rheumatology
0
0
0
Recent FDA rejections of several therapies for rare diseases have drawn criticism that argues that regulatory expectations may be becoming more difficult to meet. Is the current regulatory framework well-suited for rare disease drug development? Let us know. #RareDisease #FDA
0
0
0
ACC.26 is coming — New Orleans, March 28–30 🫀 Follow our dedicated profile on the Figure 1 app to be notified when expert insights on the latest advances in cardiovascular medicine are live: https://t.co/bDwoI58fdq
#ACC26 #Cardiology #MedEd #MedicalConference #HeartHealth
0
0
1
A painful, pruritic red plaque with erosions on the lower leg. What's your next move? Create a treatment plan for this patient and see how it compares to the real case. Take the challenge on the Figure 1 app: https://t.co/E7efcq7eMh
#MedEd #VenousStasis #VascularMedicine
0
0
1
28M, >10 bloody stools/day, spontaneous bleeding, frank ulceration, complete loss of vascular pattern. What’s the Mayo Endoscopic Score? See how you did & take the full quiz on the Figure 1 app: https://t.co/32pT9y2UgP
#MedEd #IBD #GITwitter #UlcerativeColitis
0
0
0
Is it time for rheumatologists to prescribe GLP1’s? New data hints at better disease control in rheumatic conditions, and @ebrheum discusses whether it's time for rheumatologists to start prescribing them. Read here: https://t.co/LfUG8CHIah
#Rheumatology #GLP1 #MedTwitter
0
2
5
Introducing Case Labs. Our first case explores treatment decision-making in BRCA2-mutated metastatic hormone-sensitive prostate cancer, led by @BGarmezy and @mkbupathi of @OncologyDecoded Join the debate and engage with experts for the next 30 days: https://t.co/Nlz6OJ9e4c
1
3
2
Watch @AmitGoyalMD, co-founder of @CardioNerds, break down a case where OCT confirmed acute plaque rupture—and why biomarkers didn’t tell the full story. Watch the full video: https://t.co/wg2rOk2h37
#Cardiology #UnstableAngina #MedEd
0
2
3
Pruritic plaques. Insect bites. Eosinophils on biopsy. What’s your treatment plan? Take the treatment challenge and compare your approach to the real case. https://t.co/7Cfuwm2VOf
#DermTwitter #MedEd #Dermatology
0
0
1
The final @Uromigos Year in Review episode is live — recapping 2025 bladder cancer advances, from ADCs and EV+pembro to CTDNA in risk assessment & treatment response. Listen now: https://t.co/cYDOVNav2K
0
0
0
Episode 2 of the @Uromigos Year in Review series is live. Reviewing prostate cancer developments from 2025, focusing on personalized therapy in the mHSPC setting, including PARP inhibitors, radioligands, AKT inhibitors, and ARPI use in high-risk disease.
guoncologynow.com
Silke details the 2025 prostate cancer highlights.
0
0
1
Our friends @Uromigos have a Year in Review podcast series on key renal oncology updates from 2025. Episode 1 covers RCC highlights, clinical debates, and what's coming next. Listen now:
guoncologynow.com
Brian, Tom and Silke discuss the highlights of RCC for 2025.
0
0
0
The Figure 1 team has some very exciting news to share with you! We are thrilled to be joining @physicianswkly in this next chapter of our journey.
PW is thrilled to announce the acquisition of @figure1, a unique peer-to-peer learning platform, expanding our omnichannel network by adding user-generated patient cases. Join us in welcoming Figure 1 to the PW family! https://t.co/LOl3nfN4s9
2
0
7
We have partnered with @Figure1 to present you with Complimentary app-based CME/CNE on Atopic Dermatitis with Program Chair Dr. Peter Lio! CME Activity: https://t.co/MDZyqQmPS7 CNE Activity: https://t.co/V81zpHo0iw
#Dermatology #medicaleducation #CME #CNE #MedLearningGroup
0
1
3
Congratulations to everyone who matched on #MatchDay2023! 🎉 Now how do you succeed as an intern? Read our blog post for the best tips and tricks. https://t.co/FBLsDsmOIr
0
0
4
Thank you! 🙌
Congrats!! @sololearn, @elsa_speak, @productschool, @masaischool, @nasacademy, @setupget, @figure1 have made to Emerging Startups 2023: Top Continued Learning Startups! https://t.co/7fr8eWyiAx
#online #app #data #game #emergingtech #technology #startups #soonicorns
0
0
2